{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:46:16Z","timestamp":1789685176331,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatocellular carcinoma (HCC) is the most prevalent liver malignancy, with increasing incidence and high mortality, primarily associated with hepatitis virus infection and cirrhosis. Herein, we explored the association between enhancer of zeste homolog 2 (\n                    <jats:italic>EZH2<\/jats:italic>\n                    ) expression and HCC progression, prognosis, and circadian rhythm-related genes. Differentially expressed mRNAs in HCC were identified from The Cancer Genome Atlas and Gene Expression Omnibus databases and intersected with circadian rhythm-related genes. Core genes were screened using protein\u2013protein interaction networks, least absolute shrinkage and selection operator regression, and Cox regression analysis. Functional enrichment and immune infiltration analyses were conducted using gene set variation analysis, single-sample gene set enrichment analysis, and MethSurv. Experimental validation included western blotting, small interfering RNA knockdown, reverse transcription quantitative polymerase chain reaction, and functional assays.\n                    <jats:italic>EZH2<\/jats:italic>\n                    was overexpressed in HCC and was associated with advanced tumor stage, poor prognosis, Th2 and dendritic cell infiltration, and promoter hypermethylation.\n                    <jats:italic>EZH2<\/jats:italic>\n                    knockdown inhibited proliferation, induced DNA damage, and downregulated\n                    <jats:italic>CLOCK<\/jats:italic>\n                    and\n                    <jats:italic>CRY1<\/jats:italic>\n                    expression. A prognostic nomogram integrating\n                    <jats:italic>EZH2<\/jats:italic>\n                    expression with clinicopathological parameters demonstrated strong predictive performance. Methylation analysis identified six CpG sites significantly associated with survival. In conclusion, EZH2 is a key regulator of HCC progression and potential prognostic biomarker and therapeutic target.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-26175-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:23:05Z","timestamp":1764163385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EZH2 expression in hepatocellular carcinoma and its relationship with circadian rhythm-related genes"],"prefix":"10.1038","volume":"15","author":[{"given":"Xingyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaolong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"26175_CR1","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.2174\/0929867328666211007113725","volume":"29","author":"F Faltraco","year":"2022","unstructured":"Faltraco, F. et al. Molecular link between circadian rhythmicity and mood disorders. Curr. Med. Chem. 29, 5692\u20135709. https:\/\/doi.org\/10.2174\/0929867328666211007113725 (2022).","journal-title":"Curr. Med. Chem."},{"key":"26175_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas, J. A., Kendall, B. J., El-Serag, H. B., Thrift, A. P. & Macdonald, G. A. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol. Hepatol. 9, 159\u2013169. https:\/\/doi.org\/10.1016\/S2468-1253(23)00275-3 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"26175_CR3","doi-asserted-by":"publisher","first-page":"799497","DOI":"10.3389\/fmolb.2021.799497","volume":"8","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y., Jiang, X., Tang, L., Wang, J. & Duan, L. Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer. Front. Mol. Biosci. 8, 799497. https:\/\/doi.org\/10.3389\/fmolb.2021.799497 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"26175_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.trecan.2023.11.002","volume":"10","author":"X Zhu","year":"2024","unstructured":"Zhu, X., Maier, G. & Panda, S. Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care. Trends Cancer. 10, 196\u2013207. https:\/\/doi.org\/10.1016\/j.trecan.2023.11.002 (2024).","journal-title":"Trends Cancer"},{"key":"26175_CR5","doi-asserted-by":"publisher","first-page":"e2214829120","DOI":"10.1073\/pnas.2214829120","volume":"120","author":"M Qu","year":"2023","unstructured":"Qu, M. et al. Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle. Proc. Natl. Acad. Sci. USA. 120, e2214829120. https:\/\/doi.org\/10.1073\/pnas.2214829120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26175_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.09.040","volume":"342","author":"FC Kelleher","year":"2014","unstructured":"Kelleher, F. C., Rao, A. & Maguire, A. Circadian molecular clocks and cancer. Cancer Lett. 342, 9\u201318. https:\/\/doi.org\/10.1016\/j.canlet.2013.09.040 (2014).","journal-title":"Cancer Lett."},{"key":"26175_CR7","doi-asserted-by":"publisher","unstructured":"Crespo, M., Leiva, M. & Sabio, G. Circadian clock and liver cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13143631 (2021).","DOI":"10.3390\/cancers13143631"},{"key":"26175_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-024-06462-7","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen, S., Zhang, W., Li, X., Cao, Z. & Liu, C. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1. Cell. Death Dis. 15, 78. https:\/\/doi.org\/10.1038\/s41419-024-06462-7 (2024).","journal-title":"Cell. Death Dis."},{"key":"26175_CR9","doi-asserted-by":"publisher","first-page":"116624","DOI":"10.1016\/j.biopha.2024.116624","volume":"175","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Zhu, H., Luo, Y., Tong, S. & Liu, Y. EZH2: the roles in targeted therapy and mechanisms of resistance in breast cancer. Biomed. Pharmacother. 175, 116624. https:\/\/doi.org\/10.1016\/j.biopha.2024.116624 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"26175_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40164-023-00405-2","volume":"12","author":"B Wang","year":"2023","unstructured":"Wang, B. et al. EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies. Exp. Hematol. Oncol. 12, 52. https:\/\/doi.org\/10.1186\/s40164-023-00405-2 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"26175_CR11","doi-asserted-by":"publisher","first-page":"1269378","DOI":"10.3389\/fonc.2023.1269378","volume":"13","author":"AD Jagielo","year":"2023","unstructured":"Jagielo, A. D., Benedict, C. & Spiegel, D. Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment. Front. Oncol. 13, 1269378. https:\/\/doi.org\/10.3389\/fonc.2023.1269378 (2023).","journal-title":"Front. Oncol."},{"key":"26175_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder, N. J. et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 7, 230\u2013237. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6252 (2021).","journal-title":"JAMA Oncol."},{"key":"26175_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.31659","volume":"74","author":"G Hernandez-Meza","year":"2021","unstructured":"Hernandez-Meza, G. et al. DNA methylation profiling of human hepatocarcinogenesis. Hepatology 74, 183\u2013199. https:\/\/doi.org\/10.1002\/hep.31659 (2021).","journal-title":"Hepatology"},{"key":"26175_CR14","doi-asserted-by":"publisher","first-page":"e55761","DOI":"10.1371\/journal.pone.0055761","volume":"8","author":"MA Song","year":"2013","unstructured":"Song, M. A. et al. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One. 8, e55761. https:\/\/doi.org\/10.1371\/journal.pone.0055761 (2013).","journal-title":"PLoS One"},{"key":"26175_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ncb3342","volume":"18","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing. Nat. Cell. Biol. 18, 480\u2013490. https:\/\/doi.org\/10.1038\/ncb3342 (2016).","journal-title":"Nat. Cell. Biol."},{"key":"26175_CR16","doi-asserted-by":"publisher","first-page":"9997","DOI":"10.1038\/srep09997","volume":"5","author":"XM Tan","year":"2015","unstructured":"Tan, X. M. et al. Circadian variations of clock gene Per2 and cell cycle genes in different stages of carcinogenesis in golden hamster buccal mucosa. Sci. Rep. 5, 9997. https:\/\/doi.org\/10.1038\/srep09997 (2015).","journal-title":"Sci. Rep."},{"key":"26175_CR17","doi-asserted-by":"publisher","unstructured":"Chen, S.  et al. Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma. J. Cancer 13 (2021).  https:\/\/doi.org\/10.7150\/jca.57205 (2022).","DOI":"10.7150\/jca.57205"},{"key":"26175_CR18","doi-asserted-by":"publisher","unstructured":"Liu, C., H. W., Mao, Y., Chen, W., Chen, S. Exosomal microRNAs in hepatocellular carcinoma. Cancer Cell Int. 21:254 (2021). https:\/\/doi.org\/10.1186\/s12935-021-01941-9 (2021).","DOI":"10.1186\/s12935-021-01941-9"},{"key":"26175_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neo.2014.11.004","volume":"17","author":"M Cui","year":"2015","unstructured":"Cui, M. et al. A long noncoding RNA perturbs the circadian rhythm of hepatoma cells to facilitate hepatocarcinogenesis. Neoplasia 17, 79\u201388. https:\/\/doi.org\/10.1016\/j.neo.2014.11.004 (2015).","journal-title":"Neoplasia"},{"key":"26175_CR20","doi-asserted-by":"publisher","unstructured":"Wu, Y. et al. Development and validation of a novel circadian Rhythm-related signature to predict the prognosis of the patients with hepatocellular carcinoma. Biomed. Res. Int. 2022, 4263261. https:\/\/doi.org\/10.1155\/2022\/4263261 (2022).","DOI":"10.1155\/2022\/4263261"},{"key":"26175_CR21","doi-asserted-by":"publisher","unstructured":"Huang, L. H. et al. Circadian rhythm disruption in hepatocellular carcinoma investigated by integrated analysis of bulk and Single-Cell RNA sequencing data. Int. J. Mol. Sci.  https:\/\/doi.org\/10.3390\/ijms25115748 (2024).","DOI":"10.3390\/ijms25115748"},{"key":"26175_CR22","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.21037\/tcr-23-217","volume":"12","author":"Q Liang","year":"2023","unstructured":"Liang, Q. et al. A circadian clock gene-related signature for predicting prognosis and its association with Sorafenib response in hepatocellular carcinoma. Transl Cancer Res. 12, 2493\u20132507. https:\/\/doi.org\/10.21037\/tcr-23-217 (2023).","journal-title":"Transl Cancer Res."},{"key":"26175_CR23","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.7150\/jca.71925","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Identification of circadian clock genes as regulators of immune infiltration in hepatocellular carcinoma. J. Cancer. 13, 3199\u20133208. https:\/\/doi.org\/10.7150\/jca.71925 (2022).","journal-title":"J. Cancer"},{"key":"26175_CR24","doi-asserted-by":"publisher","unstructured":"Bae, A. N., Jung, S. J., Lee, J. H., Lee, H. & Park, S. G. Clinical value of EZH2 in hepatocellular carcinoma and its potential for target therapy. Med. (Kaunas). https:\/\/doi.org\/10.3390\/medicina58020155 (2022).","DOI":"10.3390\/medicina58020155"},{"key":"26175_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s13577-019-00269-x","volume":"32","author":"WL Zhang","year":"2019","unstructured":"Zhang, W. L. et al. HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2. Hum. Cell. 32, 504\u2013514. https:\/\/doi.org\/10.1007\/s13577-019-00269-x (2019).","journal-title":"Hum. Cell"},{"key":"26175_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273. https:\/\/doi.org\/10.1038\/ng1180 (2003).","journal-title":"Nat. Genet."},{"key":"26175_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26175_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"26175_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"26175_CR30","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"26175_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Ponten","year":"2008","unstructured":"Ponten, F., Jirstrom, K. & Uhlen, M. The human protein Atlas\u2013a tool for pathology. J. Pathol. 216, 387\u2013393. https:\/\/doi.org\/10.1002\/path.2440 (2008).","journal-title":"J. Pathol."},{"key":"26175_CR32","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397. https:\/\/doi.org\/10.1002\/sim.5958 (2013).","journal-title":"Stat. Med."},{"key":"26175_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"key":"26175_CR34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003 (2013).","journal-title":"Immunity"},{"key":"26175_CR35","doi-asserted-by":"publisher","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6 (pl1). https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"26175_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002 (2017).","journal-title":"Neoplasia"},{"key":"26175_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur, V. et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10, 277\u2013288. https:\/\/doi.org\/10.2217\/epi-2017-0118 (2018).","journal-title":"Epigenomics"},{"key":"26175_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1083\/jcb.200801169","volume":"182","author":"KF Tang","year":"2008","unstructured":"Tang, K. F. et al. Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB. J. Cell. Biol. 182, 233\u2013239. https:\/\/doi.org\/10.1083\/jcb.200801169 (2008).","journal-title":"J. Cell. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26175-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26175-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26175-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:23:06Z","timestamp":1764163386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26175-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26175-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42177"}}